BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  NantHealth Reports 2020 Second Quarter Financial Results

  NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, reported financial results for its second quarter ended June 30, 2020.

  August 6, 2020

   · 

  9 min read
• Business

  Theravance Biopharma, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update

  Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today reported financial results for the second quarter ending June 30, 2020. Revenue for the second quarter 2020 was $15.0 million

  August 6, 2020

   · 

  20 min read
• Business

  Novavax and Serum Institute of India Announce Development and Commercial Collaboration

  Expected to support minimum of 1 billion doses of NVX-CoV2373 for India and low- and middle-income countries

  August 6, 2020

   · 

  8 min read
• Biotech Bay

  10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit

  10x Genomics announced the company will be participating in the upcoming UBS Genomics 2.0 and Medtech Innovations Virtual Summit.

  August 6, 2020

   · 

  1 min read
• Liminal Biosciences to Present at Canaccord 40th Annual Growth Conference

  Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company today announced that Kenneth Galbraith, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview at Canaccord 40th Annual Growth Conference

  August 6, 2020

   · 

  5 min read
• FSD Pharma Inc. Announces Closing of US$10 Million Registered Direct Offering to Institutional Investors

  FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for the purchase and sale of 2,762,430 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 1,381,215 Shares

  August 6, 2020

   · 

  4 min read
• Biotech Beach

  Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

  Illumina, Inc. (Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 Reagent Kit.

  August 6, 2020

   · 

  4 min read
• Business

  Osmotica Pharmaceuticals plc to Provide Second Quarter 2020 Business and Financial Update and Presentation on Upneeq™ on August 11, 2020

  Company to discuss launch plans for Upneeq and will be joined by Dr. Derek Cunningham, OD, FAAO

  August 6, 2020

   · 

  1 min read
• Deals

  Quanterix Prices Public Offering of Common Stock - Aug 07, 2020

  Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced the pricing of its previously announced underwritten public offering of 2,651,108 shares of its common stock at a public offering price of $32.00 per share.

  August 6, 2020

   · 

  4 min read
• Business

  Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events

  Geron Corporation, a late-stage clinical biopharmaceutical company, reported financial results for the second quarter ended June 30, 2020.

  August 6, 2020

   · 

  14 min read